In the present study, we measured the levels of circulating GDF15 and ACE2 in plasma of patients with COVID-19 who were admitted to the ICU and died and admitted to the ICU who recovered, as well as in an uninfected matched control group. The gene discussed is GDF15; the disease is COVID-19.